Clinical Trials Logo

Recurrent Thyroid Cancer clinical trials

View clinical trials related to Recurrent Thyroid Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01723202 Active, not recruiting - Clinical trials for Papillary Thyroid Cancer

Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer

Start date: November 7, 2012
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well dabrafenib works with or without trametinib in treating patients with recurrent thyroid cancer. Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether dabrafenib is more effective when given with or without trametinib in treating thyroid cancer